Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
News

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market

The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price

  • By IPP Bureau | June 07, 2022

Gufic Biosciences Limited, a fast-growing pharmaceutical player recognized for its innovative, high-quality pharmaceutical and herbal products, has targeted to capture a major share of Rs. 3,000 crore lyophilized antibacterial market in India. 

Contributing immensely to the government's ambitious Make in India drive, Gufic has collaborated with its European counterpart to manufacture this new technology indigenously in India. Until now the dual chamber bags have been largely imported in India at a very high cost to the patients. 

On the contrary, Gufic has not only launched high-quality Dual Chamber Bags at an affordable and pocket friendly price, these New Drug Delivery System products even have longer shelf life. 

Dr. Debesh Das, COO-Domestic Formulation said, 'We are committed to reduce the country's dependency on imported products especially in the critical care segment. Moving ahead with this vision we have launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price. As we are experiencing rapidly growing demand for our product we look forward to grabbing major market share in this particular segment." 

These Dual Chamber Bags launched by Gufic are 2-Chamber IV Bags made up of polypropylene (DEHP free) with a peelable aluminium foil allowing the storage of unstable drugs which need reconstitution just before the administration to the patient. The peelable seal separates lyophilized (or powder) drug and its diluent. Moreover, the product complies with the US and EU pharmacopoeias and it is manufactured in ISO7 cleanroom under cGMP. 

One of the most important USPs of these ready-to-useDual Chamber Bags by Gufic is that they prevent contamination and protect the potency and efficacy of the drug. These bags also offer ease of handling at the time of reconstitution and also help in avoiding the dilution errors since the drug is present with the exact required quantity of the diluent to be used. It can be reconstituted just before administration by simply peeling off the aluminium foil and folding & squeezing the bag, thus the diluent enters the drug chamber and mixes with the drug. It is then directly administered as IV infusion to the patient with the help of IV tubes.

Upcoming E-conference

Other Related stories

Startup

Digitization